MMMary Attia Morcos

Mary Attia Morcos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mary Attia Morcos has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Hypopigmented Interface T-Cell Dyscrasia and Hypopigmented Mycosis Fungoides: A Comparative Study

    by Randa Youssef, Doaa Mahgoub, Ola A. Zeid, Dalia M. Abdel-Halim, Marwa El-Hawary, Marwa F. Hussein, Mary A. Morcos, Dalia M. Aboelfadl, Heba A. Abdelkader, Yosra Abdel-Galeil, et al.

    Hypopigmented interface T-cell dyscrasia (HITCD) is a distinct form of lymphoid dyscrasia that may progress to hypopigmented mycosis fungoides (HMF). We compared both diseases as regards their CD4/CD8 phenotype and expression of granzyme B and tumor necrosis factor-alpha (TNF-α) and how these are affected by narrow-band UVB (nb-UVB). The study included 11 patients with HITCD and 9 patients with HMF. They received nb-UVB thrice weekly until complete repigmentation or a maximum of 48 sessions. Pretreatment and posttreatment biopsies were stained using anti CD4, CD8, TNF-α, and granzyme B monoclonal antibodies. Epidermal lymphocytes were CD8 predominant in 54.5% and 66.7% of HITCD and HMF cases, respectively, whereas dermal lymphocytes were CD4 predominant in 63.6% and 66.7%, respectively. Significantly, more dermal infiltrate was encountered in HMF (P = 0.041). In both diseases, granzyme B was only expressed in the dermis, whereas TNF-α was expressed both in the epidermis and dermis. No difference existed as regards the number of sessions needed to achieve repigmentation or cumulative nb-UVB dose reached at end of study. (P > 0.05). Narrow-band UVB significantly reduced only the epidermal lymphocytes in both diseases (P ≤ 0.05) with their complete disappearance in 8 (72.7%) HITCD and 6 (66.7%) HMF cases. In both diseases, nb-UVB did not affect granzyme B or TNF-α expression (P > 0.05). In conclusion, both diseases share the same phenotype, with HITCD being a milder form of T-cell dysfunction. In both diseases, epidermal lymphocytes are mainly CD8+-exhausted cells lacking cytotoxicity, whereas dermal cells are mostly reactive cells exerting antitumor cytotoxicity. Tumor necrosis factor-alpha mediates hypopigmentation in both diseases and prevents disease progression. Repigmentation after nb-UVB in both diseases occurs before and independently from disappearance of the dermal infiltrate.


  • 22-oxacalcitriol prevents acute kidney injury via inhibition of apoptosis and enhancement of autophagy

    by Magda Hamzawy, Sarah Ali Abdelhameed Gouda, Laila Rashed, Mary Attia Morcos, Heba Shoukry, Nivin Sharawy

    The pathophysiology of ischemic acute kidney injury (AKI) is thought to include a complex interplay between tubular cell damage and regeneration. Several lines of evidences suggest a potential renoprotective effect of vitamin D. In this study, we investigated the effect of 22-oxacalcitriol (OCT), a synthetic vitamin D analogue, on renal fate in a rat model of ischemia reperfusion injury (IRI) induced acute kidney injury (AKI).


  • The cellular selection between apoptosis and autophagy: roles of vitamin D, glucose and immune response in diabetic nephropathy

    by Magda Hamzawy, Sarah Ali Abdelhameed Gouda, Laila Rashid, Mary Attia Morcos, Heba Shoukry, Nivin Sharawy


  • Open Access

    Enhancement of Neural Stem Cells after Induction of Depression in Male Albino Rats (A histological & Immunohistochemical Study)

    by Zeinab Mohamed Kamel Ismail, Mary Attia Morcos, Mohammad Deiaa Eldin Mohammad, Alshaymaa Gamal Aboulkhair

    Depression is one of the most prevalent psychiatric disorders. Endogenous neural stem cells (NSCs) could replace damaged Hippocampal neurons in depression. This work was planned to evaluate Rhodiola rosea (Rr) extract possible role in stimulation of NSCs proliferation and in depression improvement. Thirty adult male albino rats were divided into three groups; control, untreated depressed model and Rr model. After depression induction by chronic mild stress, rats received Rr extract 1.5 g/kg/day for three weeks. The sucrose preference test (SP) was done before, after depression induction and 3 weeks after supplementation of Rr. The brain was removed and processed for H&E and immunohistochemical staining for caspase 3, glial fibrillary acid protein (GFAP) and proliferating cell nuclear antigen (PCNA). Rr group revealed improved sucrose preference, increased undamaged neurons and decreased dark neurons. Moreover, Caspase 3 +ve cells were not detected, GFAP +ve cells increased and PCNA +ve cells were detected only in Rr group. This work points to the role of Rr in depression improvement and in stimulation of NSCs proliferation.


  • Histological and immunohistochemical study on the protective effects of cetrorelix against chemotherapy-induced ovarian damage

    by Mary Attia Morcos

    Introduction Chemotherapy exerts several adverse effects on the ovaries and can lead to ovarian atrophy and infertility. Aim of the study This study was carried out to determine the possible protective effect of cetrorelix (a gonadotropine-releasing hormone antagonist) against the ovarian damage caused by a chemotherapeutic drug (cyclophosphamide). Materials and methods Thirty adult female albino rats were used in this study. They were classified into three main groups. Group I served as the control group. In group II, rats were injected intraperitoneally with cyclophosphamide. In group III, rats were injected intraperitoneally with cetrorelix in combination with cyclophosphamide. After 20 days, the rats were sacrificed and ovaries were excised and processed. Sections were stained with H&E, Masson's trichrome and immunohistochemical stains for Bcl2 (antiapoptotic gene) and FasL (proapoptotic factor). Results Cyclophosphamide injection resulted in ovarian damage in the form of depletion of ovarian follicles, apoptosis of granulosa cells (lining the follicular cavity) and cortical fibrosis. Bcl2 immunostaining was significantly decreased and FasL immunostaining significantly increased in granulosa cells in the rats of group II. Pretreatment with cyclophosphamide (group III) reversed these changes to a huge extent. Conclusion Cetrorelix reduced chemotherapy-induced ovarian damage by suppressing apoptosis.


  • Effect of doxazocin on experimentally induced prostatic hyperplasia in adult male albino rats

    by Mary Attia Morcos, Noha Mohamed Afifi

    Introduction Benign prostatic hyperplasia is a nonmalignant enlargement of the prostate that results in obstructive lower urinary tract symptoms. Doxazocin (DOX) is known to relax prostate smooth muscle through blockage of α-adrenergic receptors. This action alone does not account for the clinical responses by this drug. Aim of work The aim of this study was to investigate the effect of DOX treatment on a testosterone-induced prostatic hyperplasia model in rats. Materials and methods A total of 36 adult male albino rats were used in this study. They were divided into the following groups: a control group (group I), in which the rats received the vehicle orally; an experimental group (group II), in which rats received testosterone propionate 7.5 mg/kg/day intramuscularly for 10 days; and subgroup IIa, which received only testosterone,, and subgroups IIb, IIc, which received DOX 25 mg/kg/day orally for 7 and 30 days, respectively. Prostatic glands were excised and processed for light microscopic study using H&E stain, Masson’s trichrome stains, and immunohistochemical staining for proliferating cell nuclear antigen (PCNA) and α-smooth muscle actin (αSMA). The mean area % of collagen and of PCNA and αSMA immunoreactivity was measured using an image analyzer and the results were statistically analyzed. Results Testosterone treatment resulted in epithelial and stromal hyperplasia of the prostate. The lumina of acini were distended with secretion and separated with thick fibromuscular stroma. DOX-treated groups showed reduced epithelial and smooth muscle hyperplasia. The acini contained less secretion and were separated by thick fibromuscular stroma with fewer smooth muscle fibers. Morphometric study showed that the mean area % of PCNA and (αSMA) immunoreactivity was significantly reduced; however, the mean area % of collagen was significantly increased in the DOX-treated groups. Conclusions It was concluded that DOX treatment inhibits prostatic hyperplasia by reducing epithelial cell proliferation and smooth muscle hyperplasia. Thus, DOX is an effective drug for the treatment of benign prostatic hyperplasia.